Skip to Content
Sean Ronnekleiv-Kelly, MD

Contact Sean

E-mail:
ronnekleiv-kelly@surgery.wisc.edu

Mail:
600 Highland Ave
Madison, WI 53792

Sean Ronnekleiv-Kelly, MD

Assistant Professor
Division of Surgical Oncology
Divisions of General Surgery

Education

  • MD, University of Colorado School of Medicine, 2008
  • General Surgery Residency, University of Wisconsin School of Medicine and Public Health, 2015
  • Complex General Surgical Oncology Fellowship, Johns Hopkins Hospital, 2017

Clinical Specialties

Certified by the American Board of Surgery in General Surgery and specializes in malignant disease of the pancreas, liver, gallbladder and biliary tree, stomach and small intestine, neuroendocrine tumors and retroperitoneal sarcoma.

Research Interests

Principal research interest is pancreatic cancer. My lab focuses on formation and progression of pancreatic cancer as well as understanding communication within the tumor microenvironment.

Recent Publications
  • Epigenetic therapy and chemosensitization in solid malignancy.
    Ronnekleiv-Kelly SM, Sharma A, Ahuja N
    Cancer Treat. Rev. 2017 Apr; 55():200-208.
    [PubMed ID: 28431263]
    More Information
  • Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review.
    Moris D, Ronnekleiv-Kelly S, Rahnemai-Azar AA, Felekouras E, Dillhoff M, Schmidt C, Pawlik TM
    J. Gastrointest. Surg. 2017 Jun; 21(6):1076-1085.
    [PubMed ID: 28364212]
    More Information
  • The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse.
    Díaz-Díaz CJ, Ronnekleiv-Kelly SM, Nukaya M, Geiger PG, Balbo S, Dator R, Megna BW, Carney PR, Bradfield CA, Kennedy GD
    Ann. Surg. 2016 Sep; 264(3):429-36.
    [PubMed ID: 27433903, PMC ID: 5125557]
    More Information
  • Molecular markers of prognosis and therapeutic targets in metastatic colorectal cancer.
    Ronnekleiv-Kelly SM, Burkhart RA, Pawlik TM
    Surg Oncol 2016 Sep; 25(3):190-9.
    [PubMed ID: 27566022, PMC ID: 5152574]
    More Information
  • Aryl hydrocarbon receptor-dependent apoptotic cell death induced by the flavonoid chrysin in human colorectal cancer cells.
    Ronnekleiv-Kelly SM, Nukaya M, Díaz-Díaz CJ, Megna BW, Carney PR, Geiger PG, Kennedy GD
    Cancer Lett. 2016 Jan 01; 370(1):91-9.
    [PubMed ID: 26515162, PMC ID: 4698318]
    More Information

webmaster@surgery.wisc.edu Copyright © 2017 The Board of Regents of the University of Wisconsin System